- Home
- BBIO vs MAA Comparison
BBIO vs MAA Comparison
Compare BBIO & MAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- MAA
- Stock Information
- Founded
- BBIO 2015
- MAA 1977
- Country
- BBIO United States
- MAA United States
- Employees
- BBIO N/A
- MAA 2532
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- MAA Real Estate Investment Trusts
- Sector
- BBIO Health Care
- MAA Real Estate
- Exchange
- BBIO Nasdaq
- MAA Nasdaq
- Market Cap
- BBIO 6.7B
- MAA 19.0B
- IPO Year
- BBIO 2019
- MAA 1994
- Fundamental
- Price
- BBIO $34.83
- MAA $161.65
- Analyst Decision
- BBIO Strong Buy
- MAA Buy
- Analyst Count
- BBIO 12
- MAA 20
- Target Price
- BBIO $57.09
- MAA $175.00
- AVG Volume (30 Days)
- BBIO 3.2M
- MAA 930.1K
- Earning Date
- BBIO 04-29-2025
- MAA 04-30-2025
- Dividend Yield
- BBIO N/A
- MAA 3.75%
- EPS Growth
- BBIO N/A
- MAA 0.75
- EPS
- BBIO N/A
- MAA 4.81
- Revenue
- BBIO $127,415,000.00
- MAA $2,196,688,000.00
- Revenue This Year
- BBIO $13.67
- MAA $2.65
- Revenue Next Year
- BBIO $118.02
- MAA $3.82
- P/E Ratio
- BBIO N/A
- MAA $34.29
- Revenue Growth
- BBIO N/A
- MAA 1.55
- 52 Week Low
- BBIO $21.62
- MAA $126.77
- 52 Week High
- BBIO $39.47
- MAA $173.38
- Technical
- Relative Strength Index (RSI)
- BBIO 46.94
- MAA 51.32
- Support Level
- BBIO $36.85
- MAA $163.48
- Resistance Level
- BBIO $39.16
- MAA $166.04
- Average True Range (ATR)
- BBIO 1.47
- MAA 3.46
- MACD
- BBIO -0.07
- MAA 0.72
- Stochastic Oscillator
- BBIO 25.61
- MAA 53.18
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.